Tempus AI (NASDAQ:TEM) Trading Up 11.3% – Should You Buy?

Tempus AI, Inc. (NASDAQ:TEM)’s stock price was up 11.3% during trading on Friday . The stock traded as high as $46.07 and last traded at $46.94. Approximately 4,486,208 shares were traded during mid-day trading, a decline of 8% from the average daily volume of 4,902,042 shares. The stock had previously closed at $42.17.

Analyst Ratings Changes

Several equities analysts recently commented on TEM shares. Piper Sandler dropped their price objective on shares of Tempus AI from $70.00 to $55.00 and set a “neutral” rating for the company in a research note on Tuesday, March 4th. Needham & Company LLC increased their price objective on shares of Tempus AI from $56.00 to $70.00 and gave the company a “buy” rating in a research note on Tuesday, February 25th. Guggenheim reissued a “buy” rating on shares of Tempus AI in a research note on Tuesday, February 25th. William Blair reissued a “market perform” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Finally, TD Cowen reissued a “buy” rating and issued a $74.00 price objective (up previously from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $61.18.

Tempus AI Stock Up 11.9 %

The company’s 50 day moving average price is $55.33 and its 200-day moving average price is $51.71. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Insider Transactions at Tempus AI

In other news, Director Nadja West sold 809 shares of the stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $51.11, for a total transaction of $41,347.99. Following the completion of the sale, the director now directly owns 37,705 shares in the company, valued at $1,927,102.55. This represents a 2.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Eric P. Lefkofsky sold 3,240,234 shares of the stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $58.75, for a total transaction of $190,363,747.50. Following the sale, the chief executive officer now owns 4,895,589 shares of the company’s stock, valued at approximately $287,615,853.75. This trade represents a 39.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 5,755,906 shares of company stock worth $322,788,693 over the last three months.

Institutional Investors Weigh In On Tempus AI

A number of large investors have recently bought and sold shares of TEM. Operose Advisors LLC bought a new stake in Tempus AI in the fourth quarter valued at $25,000. First Horizon Advisors Inc. bought a new stake in shares of Tempus AI during the third quarter worth about $30,000. Farther Finance Advisors LLC bought a new stake in shares of Tempus AI during the fourth quarter worth about $34,000. Prestige Wealth Management Group LLC boosted its holdings in Tempus AI by 910.4% during the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after purchasing an additional 965 shares during the last quarter. Finally, NewEdge Advisors LLC purchased a new position in Tempus AI during the fourth quarter worth about $49,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.